Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test.

Lawn SD, Mwaba P, Bates M, Piatek A, Alexander H, Marais BJ, Cuevas LE, McHugh TD, Zijenah L, Kapata N, Abubakar I, McNerney R, Hoelscher M, Memish ZA, Migliori GB, Kim P, Maeurer M, Schito M, Zumla A.

Lancet Infect Dis. 2013 Apr;13(4):349-61. doi: 10.1016/S1473-3099(13)70008-2. Epub 2013 Mar 24. Review.

2.

Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.

Scott LE, McCarthy K, Gous N, Nduna M, Van Rie A, Sanne I, Venter WF, Duse A, Stevens W.

PLoS Med. 2011 Jul;8(7):e1001061. doi: 10.1371/journal.pmed.1001061. Epub 2011 Jul 26.

3.

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.

Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, Huang L, Caceres T, Mehdiyev R, Raymond L, Whitelaw A, Sagadevan K, Alexander H, Albert H, Cobelens F, Cox H, Alland D, Perkins MD.

Lancet. 2011 Apr 30;377(9776):1495-505. doi: 10.1016/S0140-6736(11)60438-8. Epub 2011 Apr 18.

4.

The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.

Pimkina E, Zablockis R, Nikolayevskyy V, Danila E, Davidaviciene E.

Respir Med. 2015 Nov;109(11):1484-9. doi: 10.1016/j.rmed.2015.07.006. Epub 2015 Jul 11.

PMID:
26403251
5.

Xpert MTB/RIF test for tuberculosis.

Ferrara G, O'Grady J, Zumla A, Maeurer M.

Lancet. 2011 Aug 6;378(9790):482; author reply 482-3. doi: 10.1016/S0140-6736(11)61244-0. No abstract available.

PMID:
21821179
6.

Microscopic observation drug-susceptibility assay vs. Xpert® MTB/RIF for the diagnosis of tuberculosis in a rural African setting: a cost-utility analysis.

Wikman-Jorgensen PE, Llenas-García J, Pérez-Porcuna TM, Hobbins M, Ehmer J, Mussa MA, Ascaso C.

Trop Med Int Health. 2017 Jun;22(6):734-743. doi: 10.1111/tmi.12879. Epub 2017 May 2.

PMID:
28380276
7.

Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.

Rachow A, Zumla A, Heinrich N, Rojas-Ponce G, Mtafya B, Reither K, Ntinginya EN, O'Grady J, Huggett J, Dheda K, Boehme C, Perkins M, Saathoff E, Hoelscher M.

PLoS One. 2011;6(6):e20458. doi: 10.1371/journal.pone.0020458. Epub 2011 Jun 29.

8.

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, Dendukuri N.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD009593. doi: 10.1002/14651858.CD009593.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;(1):CD009593.

9.

Xpert MTB/RIF test for tuberculosis.

Theron G, Peter J, Dheda K.

Lancet. 2011 Aug 6;378(9790):481; author reply 482-3. doi: 10.1016/S0140-6736(11)61242-7. No abstract available.

PMID:
21821176
10.

Comparison of Xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis.

Rufai SB, Kumar P, Singh A, Prajapati S, Balooni V, Singh S.

J Clin Microbiol. 2014 Jun;52(6):1846-52. doi: 10.1128/JCM.03005-13. Epub 2014 Mar 19.

11.

Xpert MTB/RIF test for tuberculosis.

Salvo F, Sadutshang TD, Migliori GB, Zumla A, Cirillo DM.

Lancet. 2011 Aug 6;378(9790):481-2; author reply 482-3. doi: 10.1016/S0140-6736(11)61243-9. No abstract available.

PMID:
21821177
12.

Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.

Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S, Dawson R, Whitelaw A, Hoelscher M, Sharma S, Pai M, Warren R, Dheda K.

Am J Respir Crit Care Med. 2011 Jul 1;184(1):132-40. doi: 10.1164/rccm.201101-0056OC. Epub 2011 Apr 14.

PMID:
21493734
13.

Diagnosing pulmonary tuberculosis with the Xpert MTB/RIF test.

Bodmer T, Ströhle A.

J Vis Exp. 2012 Apr 9;(62):e3547. doi: 10.3791/3547.

14.

Diagnostic accuracy and turnaround time of the Xpert MTB/RIF assay in routine clinical practice.

Kwak N, Choi SM, Lee J, Park YS, Lee CH, Lee SM, Yoo CG, Kim YW, Han SK, Yim JJ.

PLoS One. 2013 Oct 29;8(10):e77456. doi: 10.1371/journal.pone.0077456. eCollection 2013.

15.

Diagnostic yield of Bronchoalveolar Lavage gene Xpert in smear-negative and sputum-scarce pulmonary tuberculosis.

Khalil KF, Butt T.

J Coll Physicians Surg Pak. 2015 Feb;25(2):115-8. doi: 02.2015/JCPSP.115118.

PMID:
25703755
17.

Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation.

Menzies NA, Cohen T, Lin HH, Murray M, Salomon JA.

PLoS Med. 2012;9(11):e1001347. doi: 10.1371/journal.pmed.1001347. Epub 2012 Nov 20.

18.

Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.

Mavenyengwa RT, Shaduka E, Maposa I.

Infect Dis Poverty. 2017 Jan 11;6(1):13. doi: 10.1186/s40249-016-0213-y.

19.
20.

False-positive rifampicin resistance on Xpert® MTB/RIF: case report and clinical implications.

Van Rie A, Mellet K, John MA, Scott L, Page-Shipp L, Dansey H, Victor T, Warren R.

Int J Tuberc Lung Dis. 2012 Feb;16(2):206-8. doi: 10.5588/ijtld.11.0395.

Supplemental Content

Support Center